Bryan Cave is advising Zevra, and Pillsbury is advising Acer Therapeutics. Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) and Acer Therapeutics Inc. (Nasdaq: ACER) announced the companies have entered into...
You must be a Standard 1 Year member to access this content.
Pillsbury Winthrop Shaw Pittman LLP advised Invitae on the deal. Leading medical genetics company Invitae announced the sale of Research Use Only (RUO) kitted solutions by Integrated...
You must be a Standard 1 Year member to access this content.
Pillsbury Winthrop Shaw Pittman LLP advised Chevron New Energies on the deal. Chevron New Energies (CNE) served as the lead investor to carbon technology company Svante...
You must be a Standard 1 Year member to access this content.
Pillsbury advised Chevron Corporation on the deal. Chevron Corporation, through its Chevron New Energies business, announced its recent collaboration with Baseload Capital to develop geothermal projects in...
You must be a Standard 1 Year member to access this content.
Pillsbury Winthrop Shaw Pittman advised Chevron New Energies on the deal. Chevron New Energies announced its Series A investment in Zero Emission Industries, Inc. (ZEI), a hydrogen...
You must be a Standard 1 Year member to access this content.
Pillsbury advised the California Public Employees’ Retirement System (CalPERS) on the deal. The California Public Employees’ Retirement System (CalPERS) announced its divestiture of $6 billion in private...
You must be a Standard 1 Year member to access this content.
Pillsbury Winthrop Shaw Pittman advised Shield AI on the deal. Shield AI raised $90 million in equity and $75 million in debt as part of a...
You must be a Standard 1 Year member to access this content.
